← Back to Search

Dural Graft

surgery - non-autologous graft for Chiari Malformation (DECOMPRESS Trial)

N/A
Waitlist Available
Led By Robert F Spetzler, M.D.
Research Sponsored by St. Joseph's Hospital and Medical Center, Phoenix
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This research study is to find out which types of dural grafts used during surgery for Chiari Malformations are superior. We believe that autologous dural grafts are superior to non-autologous grafts.

Eligible Conditions
  • Chiari Malformation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Complications encountered during the subject's post-operative care

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: surgery - non-autologous graftActive Control1 Intervention
surgical intervention: decompression of Chiari malformation by suboccipital craniectomy using using non-autologous graft
Group II: surgery - autologous graftActive Control1 Intervention
surgical intervention: decompression of Chiari malformation by suboccipital craniectomy using autologous graft

Find a Location

Who is running the clinical trial?

St. Joseph's Hospital and Medical Center, PhoenixLead Sponsor
67 Previous Clinical Trials
17,323 Total Patients Enrolled
Robert F Spetzler, M.D.Principal InvestigatorBarrow Neurosurgical Associates
~3 spots leftby Nov 2025